What Noom Med Actually Costs at Maintenance
At maintenance doses, Noom Med's real pricing structure is often misunderstood at enrollment. The advertised "$69/month" is a base membership fee — not the medication. Full-dose compounded semaglutide runs approximately $279/month, billed as $837 for a 12-week cycle with no monthly payment option. Luma Health delivers the same compounded semaglutide at $197/month flat — billed monthly, with no coaching bundle and no quarterly lock-in.
Noom Med True Cost at Maintenance — June 2026
If you reached maintenance and found you're not consistently using Noom's CBT coaching and app features, you are paying the base membership fee for services that aren't adding clinical value. Switching to a medication-focused platform at maintenance is a common and clinically sound decision — particularly since Noom Med locks full-dose patients into a 12-week billing cycle rather than month-to-month.
Full Cost Comparison at Maintenance
| Factor | Noom Med | Luma Health |
|---|---|---|
| Sema at maintenance | ~$279/mo (quarterly billing) | $197/mo flat, monthly |
| Annual sema total | ~$3,348/yr | $2,364/yr |
| Tirzepatide | Not offered | ✓ $297/mo flat |
| Coaching | ✓ CBT-based (base membership) | Not included |
| Billing flexibility | Quarterly lock-in at full dose | Monthly, cancel anytime |
| Pharmacy named | No | ✓ VialsRX TX#35264 |
For patients at maintenance doses who are not consistently using Noom's CBT coaching, Luma Health delivers equivalent clinical outcomes — the same active semaglutide molecule — at a meaningfully lower and more flexible cost. The clinical outcome (GLP-1 receptor activation at the same dose) is identical regardless of platform; what changes is monthly cost, billing flexibility, and whether tirzepatide is even an option.
Same molecule.
Lower cost, billed monthly.
$197/mo sema flat · $297/mo tirz flat (Noom doesn't offer tirz). VialsRX (TX #35264). No contracts.
Switch to Luma Health →Free Alternatives to Noom's Coaching at Maintenance
Noom Med's group coaching provides accountability and peer support. Free alternatives: r/semaglutide and r/Tirzepatide on Reddit (active, candid, peer-sourced support), r/loseit for broader weight loss community, and Facebook groups for GLP-1 users — typically larger and more candid than platform-managed groups. For structured clinical support, a monthly session with a registered dietitian who specializes in GLP-1 patients (~$80–$150/session, paid only when used) is often more clinically specialized than general CBT coaching.
Frequently Asked Questions
Full-dose compounded semaglutide through Noom Med runs approximately $279/month, billed as $837 for a 12-week cycle with no monthly payment option. This is separate from the ~$69/month base membership fee that's often advertised as the headline price. Compare this to Luma Health's $197/month flat, billed monthly.
No — as long as you continue weekly injections at your current dose without a gap. STEP 4 data (Rubino et al., JAMA 2021) confirmed continued treatment maintains results, while discontinuation leads to regain. The switch itself doesn't affect outcomes; only a treatment gap would.
Not through Noom Med — it does not offer compounded tirzepatide in any form. If you want to try tirzepatide after plateauing on semaglutide, Luma Health offers it at $297/month flat as a direct next step.
Start Luma Health's intake at start.mylumahealth.com while you still have 2–3 weeks of Noom Med medication remaining. Provide your current maintenance dose — Wasef Health, PC will prescribe at that same dose, no re-titration. Wait for VialsRX shipping confirmation before canceling Noom Med, and cancel any separate app subscription as well.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed 33755728
- Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28:2083–2091. PubMed 36216945
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- Noom Health. Noom Med Official Program and Pricing. noom.com
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov